Gautam Patel Receives Stock Award at Amneal Pharmaceuticals Inc (AMRX) — SEC Form 4, Aug 12, 2026

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Gautam Patel

Director

TXN 2026-08-10 · FILED 2026-08-12

Equity Position 1.93M sh 1,643,963 → 1,927,595

Equity Change +17.3% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Amneal Pharmaceuticals Inc

AMRX CIK 0001723128

Reporting Owner

Name	Relationship
Gautam Patel CIK 0001738054	Director

Gautam Patel at Amneal Pharmaceuticals Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Amneal Pharmaceuticals Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Class A Common StockF1 F1	2026-08-10	A - Award/Grant	283,632 A		—	283,632	Indirect By Limited Liability Company

Non-Derivative Holdings

Title	Shares Held	Ownership
Class A Common Stock	1,643,963	Direct

Footnotes (1)

F1: On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock). Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 283,632 shares of Class A Common Stock in the Acquisition. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 6 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Amneal Pharmaceuticals Inc

GET /v1/forms/4/0001628280-26-056288 API docs